Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07784894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential

Name: A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential — clinical trial record (NCT07784894)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorGlaxoSmithKline

Started2026-09-01

View on ClinicalTrials.gov ↗

This study is designed to assess the pharmacokinetics (PK), safety, and tolerability of Ganfeborole and Microgynon, an oral contraceptive containing ethinylestradiol (EE) and levonorgestrel (LNG), when Microgynon is administered alone and in combination with Ganfeborole in healthy female participants of non-childbearing potential.

Trial Details

NCT Number	NCT07784894
Lead Sponsor	GlaxoSmithKline Collaborators: UNITE4TB consortium
Conditions	Tuberculosis
Enrollment	28 participants
Start Date	2026-09-01
Primary Completion	2026-11-24 (estimated)
Study Completion	2026-11-24 (estimated)
Updated on ClinicalTrials.gov	2026-08-25